Beta-blocker therapy is a pharmacological approach widely employed in cardiovascular medicine to manage various conditions. These medications, known as beta-blockers, function by blocking the effects of adrenaline, thus reducing heart rate and blood pressure. Beta blockers have proven efficacy in treating conditions such as hypertension, angina, and certain cardiac arrhythmias. They are also commonly prescribed for heart failure patients to improve cardiac function and reduce symptoms. Moreover, beta-blocker therapy plays a crucial role in post-myocardial infarction care, aiding in preventing secondary cardiovascular events. The versatility of beta blockers extends beyond cardiovascular applications, as they are sometimes used to alleviate symptoms associated with anxiety and migraine headaches. While well-tolerated by many patients, it is essential to consider individual medical histories and potential contraindications when prescribing beta-blocker therapy. As with any medical intervention, close collaboration between healthcare providers and patients ensures the optimal management of cardiovascular health
.
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain